The cancer prevention study ii cps ii , which began in 1982, is a prospective mortality study of approximately 1.2 million american men and women. Approximately 77,0 volunteers for the american cancer society recruited participants into the study in all 50 states, the district of columbia, and puerto rico. During the 24 years of completed mortality follow up currently available for this cohort 1982 2006 , 491,188 deaths have occurred cause of death has been obtained for 99.3% of all deaths. Follow up of cps ii is expected to continue for many years to maximize the information obtained from this valuable study. The cps ii project also includes the cps ii nutrition survey and the cps ii biorepository.

Place this order or a similar order with us today and get an amazing discount cancer preventionresearch capr print issn: 1940 6207 online issn: 1940 6215 is published monthly, one volume/year, by the american association for cancer research, inc. Phone: 215 440 9300 toll free: 866 423 3965 fax: 215 440 9337 e mail: [email protected]. scope: cancer prevention research is devoted exclusively to cancer prevention. The journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them.

Essays on Communication

cancer prevention research comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. The journal is printed on paper that meets the requirements of ansi/niso z39.48 1992 permanence of paper. Lippman, md, editor in chief c/o cancer prevention research 615 chestnut st. 17th floor, philadelphia, pa 19106 4404 phone: 215 440 9300 or toll free: 866 423 3965 fax: 215 440 9337 e mail: [email protected] see instructions for authors for manuscript submission information.

Place this order or a similar order with us today and get an amazing discount the cancer prevention and control research network is a national network recently established to focus on developing new interventions and disseminating and translating proven interventions into practice to reduce cancer burden and disparities, especially among minority and medically underserved populations. Jointly funded by the centers for disease control and prevention and the national cancer institute, the cancer prevention and control research network consists of sites administered through prevention research centers funded by the centers for disease control and prevention. The five sites are located in kentucky, massachusetts, south carolina, texas, washington state, and west virginia. The cancer prevention and control research network's intervention areas include primary prevention of cancer through healthy eating, physical activity, sun avoidance, tobacco control, and early detection of cancer through screening. The cancer prevention and control research network uses the methods of community based participatory research and seeks to build on the cancer relevant systematic reviews of the guide to community preventive services.

Initial foci for the cancer prevention and control research network's research work groups include projects to increase screening for breast, cervical, and colorectal cancers to promote informed decision making for prostate cancer screening and to validate educational materials developed for low literacy populations. The cancer prevention and control research network cpcrn is a federally funded, national network of academic, public health, and community partnerships that work together to reduce the burden of cancer, especially among those disproportionately affected. The cpcrn was initiated in october 2002, with funding from the centers for disease control and prevention cdc and the national cancer institute nci as part of their effort to more effectively translate research into practice. The five cpcrn sites were selected through a competition among the cdc funded prevention research centers prcs. Three sites are operated by individual universities: the universities of south carolina, texas houston, and washington. Two sites are operated jointly by pairs of universities: boston and harvard universities and the university of kentucky and west virginia university.

This paper introduces the cpcrn outlines the context for its creation, along with its goals, structure, and operations and summarizes progress to date. Although the cpcrn sites carry out most of their work locally, the cpcrn is a national network and was developed in a national context. The cpcrn is a further step in efforts by two federal agencies, the cdc and the nci, to translate research into practice with potential for reducing the cancer burden in the united states, especially among populations that are disproportionately affected. First, the cancer burden in the united states remains high, and disparities in incidence and mortality persist. Second, one of the best opportunities to reduce these disparities is through community based participatory research. Third, recently published syntheses of research, such as the cdc's guide to community preventive services community guide 1 , suggest specific areas where carefully evaluated dissemination research is needed. Finally, the cdc's prc program 2 , with its focus on community based participatory research cbpr and translation, provides a unique combination of trained, experienced investigators and infrastructure to support a network like the cpcrn.

The creation of the cpcrn is, in part, a response to the growing magnitude of and persistent disparities in cancer burden. Cancer is the second leading cause of death in the united states as well as a leading cause of morbidity. Cancer accounts for one of every four deaths 3 , and, in 2004, 563,700 people are expected to die of cancer. In 2004, 1,368,030 new cancer cases are expected to be diagnosed in the united states 3 , not including carcinoma in situ or basal and squamous cell skin cancers. The top four cancer sites with expected numbers of cases are prostate 230,110 , breast 217,440 , lung 173,770 , and colorectal 150,950. In addition, more than 1 million cases of basal and squamous cell skin cancer are expected to be diagnosed in 2004 disparities in cancer incidence and mortality persist.